Table 3 SIRs and 95% CIs for a cancer diagnosis in patients with a diagnosis of epistaxis or haemoptysis, Denmark 1995–2013

From: Risk of cancer in patients with epistaxis and haemoptysis

Follow-up time All cancers Haematological cancers Immune-related cancers Smoking and alcohol-related cancers All other sites
Epistaxis Obs/Exp SIR (95% CI) Obs/Exp SIR (95% CI) Obs/Exp SIR (95% CI) Obs/Exp SIR (95% CI) Obs/Exp SIR (95% CI)
Overall 9173/7737 1.19 (1.16, 1.21) 573/436 1.31 (1.21, 1.42) 2460/2313 1.06 (..02, 1.11) 3500/2706 1.29 (1.25, 1.34) 2640/2282 1.16 (1.11, 1.20)
0 to 90 days 743/155 1.85 (1.69, 2.02) 86/15 5.78 (4.62, 7.14) 86/71 1.21 (0.97, 1.49) 148/94 1.58 (1.34, 1.86) 153/76 2.01 (1.70, 2.36)
91 days to 365 days 893/736 1.21 (1.13, 1.29) 74/43 1.73 (1.36, 2.17) 237/206 1.15 (1.01, 1.31) 337/269 1.25 (1.12, 1.39) 245/219 1.12 (0.98, 1.27)
>1 to 5 years 3642/3085 1.18 (1.14, 1.22) 207/176 1.17 (1.02, 1.35) 950/885 1.07 (1.01, 1.14) 1415/1106 1.28 (1.21, 1.35) 1070/917 1.17 (1.10, 1.24)
>5–14 years 4165/3660 1.14 (1.10, 1.17) 206/203 1.02 (0.88, 1.17) 1187/1150 1.03 (0.97, 1.09) 1600/1237 1.29 (1.23, 1.36) 1172/1070 1.10 (1.03, 1.16)
Haemoptysis
Overall 2582/1540 1.68 (1.61, 1.74) 127/84 1.51 (1.26, 1.79) 483/466 1.04 (0.95, 1.13) 1449/521 2.78 (2.64, 2.93) 523/468 1.12 (1.02, 1.22)
0 to 90 days 695/48 14.6 (13.5, 15.7) 19/3 7.03 (4.23, 11.0) 9/14 0.66 (0.30, 1.26) 611/17 36.3 (33.5, 39.3) 56/15 3.86 (2.91, 5.01)
91 days to 365 days 232/136 1.70 (1.49, 1.94) 14/8 1.82 (0.99, 3.05) 42/39 1.08 (0.78, 1.46) 129/48 2.69 (2.25, 3.20) 47/42 1.13 (0.83, 1.50)
>1 to 5 years 750/596 1.26 (1.17, 1.35) 37/33 1.11 (0.78, 1.54) 191/175 1.09 (0.94, 1.26) 318/206 1.54 (1.38, 1.72) 204/182 1.12 (0.97, 1.28)
>5–14 years 905/760 1.19 (1.11, 1.27) 57/41 1.40 (1.06, 1.82) 241/239 1.01 (0.88, 1.14) 391/251 1.56 (1.41, 1.72) 216/229 0.94 (0.82, 1.08)
  1. Abbreviations: CI=confidence interval; Obs/exp=observed number/expected number; SIR=standardised incidence ratios.